The Biology of Your Diagnosis
At a Glance
Graham Little-Piccardi-Lassueur Syndrome (GLPLS) is an immune condition where T-cells attack hair follicle stem cells. This causes permanent scarring hair loss on the scalp, but non-scarring loss in the armpits and groin. Doctors confirm GLPLS using trichoscopy and a scalp biopsy.
Understanding the biology of Graham Little-Piccardi-Lassueur Syndrome (GLPLS) helps demystify why your body is changing. At its core, GLPLS is a “miscommunication” within your immune system. While it is often confused with other conditions, it has a very specific biological signature that sets it apart.
The Biological “Attack”
In GLPLS, your immune system’s “soldiers”—specifically T-lymphocytes—mistakenly target the hair follicles on your scalp [1][2]. They focus their attack on a critical area called the bulge, which houses the stem cells responsible for regenerating hair [3].
When these stem cells are attacked, they release inflammatory signals like interferon-gamma [4]. This triggers a process called fibrosis, where the delicate hair-producing cells are replaced by tough, non-functional scar tissue [3][4]. Once this scar tissue forms, the hair follicle is essentially “retired,” which is why scalp hair loss in GLPLS is permanent.
Scarring vs. Non-Scarring: A Tale of Two Patterns
One of the most confusing aspects of GLPLS is that it causes two different types of hair loss in different parts of your body:
- Cicatricial (Scarring): On the scalp, the immune attack is deep and destructive. It destroys the follicle’s “engine” (the stem cells), leading to permanent loss [5][2].
- Non-Cicatricial (Non-Scarring): In the armpits and groin, the hair falls out, but the follicles themselves are usually spared from permanent scarring [5]. This means the underlying skin structure remains intact, even though the hair is gone.
Identifying the “Look-Alikes”
Because GLPLS is rare, doctors must carefully rule out other conditions that cause patchy hair loss. This process is called differential diagnosis.
| Condition | How It Differs from GLPLS | How Doctors Tell the Difference |
|---|---|---|
| Discoid Lupus Erythematosus (DLE) | Causes similar scarring but often features red, scaly “disks” on the face or ears. | Doctors use a special biopsy stain called CD123. Large clusters of these cells strongly point to DLE [6]. |
| Frontal Fibrosing Alopecia (FFA) | A highly common variant of Lichen Planopilaris that typically causes a receding hairline at the front and sides of the scalp, often with eyebrow loss. | FFA typically lacks the specific “triad” of body bumps and axillary loss seen in GLPLS, and presents with a distinct “band-like” recession pattern [7]. |
| Central Centrifugal Cicatricial Alopecia (CCCA) | Typically starts at the crown (top) of the head and spreads outward in a circular pattern. | CCCA lacks the “triad” of body bumps and armpit hair loss seen in GLPLS [5]. |
| Alopecia Areata | A common form of hair loss that is non-scarring; the hair can often grow back. | A biopsy of GLPLS will show permanent scarring and a lack of hair pores (ostia), which are still present in Alopecia Areata [8]. |
How Doctors Confirm the Diagnosis
To distinguish GLPLS from these look-alikes, your doctor may use trichoscopy (a high-powered magnification of the scalp) to look for the absence of hair pores and specific patterns of redness [8]. However, the “gold standard” is a scalp biopsy, where a tiny piece of skin is examined under a microscope to confirm the specific lymphocytic attack and the presence of fibrosis [2][9].
Common questions in this guide
What causes hair loss in GLPLS?
Will my hair grow back if I have Graham Little-Piccardi-Lassueur Syndrome?
How do doctors confirm a GLPLS diagnosis?
How is GLPLS different from Alopecia Areata?
Why might my doctor perform a CD123 stain on my biopsy?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Was a CD123 stain performed on my scalp biopsy to help rule out Discoid Lupus Erythematosus?
- 2.Did the biopsy show evidence of 'epithelial-to-mesenchymal transition' or stem cell destruction?
- 3.Is the inflammation currently centered around the 'bulge' of the hair follicles?
- 4.Based on the biopsy and trichoscopy, how confident are we that this is GLPLS rather than another variant of Lichen Planopilaris?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (9)
- 1
Exploring the association between lichen planopilaris, cardiovascular and metabolic disorders.
Conic RRZ, Maghfour J, Damiani G, Bergfeld W
Journal of the European Academy of Dermatology and Venereology : JEADV 2021; (35(11)):e826-e828 doi:10.1111/jdv.17513.
PMID: 34242427 - 2
Lichen planopilaris in a Latin American (Chilean) population: demographics, clinical profile and treatment experience.
Mardones F, Shapiro J
Clinical and experimental dermatology 2017; (42(7)):755-759 doi:10.1111/ced.13203.
PMID: 28748570 - 3
Epithelial-to-Mesenchymal Stem Cell Transition in a Human Organ: Lessons from Lichen Planopilaris.
Imanishi H, Ansell DM, Chéret J, et al.
The Journal of investigative dermatology 2018; (138(3)):511-519 doi:10.1016/j.jid.2017.09.047.
PMID: 29106928 - 4
Single-cell sequencing combined with spatial transcriptomics reveals the characteristics of follicle-targeted inflammation patterns in primary cicatricial alopecia.
Chen Q, Li Y, Zhu Q, et al.
Cell & bioscience 2025; (15(1)):102 doi:10.1186/s13578-025-01447-1.
PMID: 40671126 - 5
Graham-Little-Piccardi-Lassueur Syndrome with Mucosal Involvement: A Rare Case.
Polra RV, Tandel JJ, Nair PA
International journal of trichology 2023; (15(6)):251-254 doi:10.4103/ijt.ijt_88_22.
PMID: 39600425 - 6
Different distribution patterns of plasmacytoid dendritic cells in discoid lupus erythematosus and lichen planopilaris demonstrated by CD123 immunostaining.
Rakhshan A, Toossi P, Amani M, et al.
Anais brasileiros de dermatologia 2020; (95(3)):307-313 doi:10.1016/j.abd.2019.11.005.
PMID: 32299739 - 7
Rapidly progressive diffuse fibrosing alopecia.
Du X, Li Z, Zhu Q, et al.
JAAD case reports 2019; (5(10)):883-887 doi:10.1016/j.jdcr.2019.07.025.
PMID: 31681827 - 8
Trichoscopic Differentiation in Alopecia: Retrospective Case Series Comparing Lichen Planopilaris, Discoid Lupus Erythematosus, and Alopecia Areata.
Kaya G
JMIR dermatology 2025; (8()):e83463 doi:10.2196/83463.
PMID: 41264867 - 9
Direct immunofluorescence findings in cicatricial alopecia: A retrospective study of 155 cases.
Agarwal R, Singh M, Dahiya R, et al.
Indian journal of pathology & microbiology 2019; (62(1)):103-106 doi:10.4103/IJPM.IJPM_428_18.
PMID: 30706869
This page explains the biology and diagnosis of Graham Little-Piccardi-Lassueur Syndrome for educational purposes. Always consult a board-certified dermatologist for proper diagnosis and interpretation of your biopsy results.
Get notified when new evidence is published on Graham Little-Piccardi-Lassueur syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.